UBS Group’s Proterra Inc. Warrant PTRAW Stock Holding History

UBS Group’s Portfolio PTRAW Stock Details PTRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,597	Closed	-$33K	–	11373
2021 Q3	$33K	Buy	+12,597	New	+$42.1K	﹤0.01%	6681
2021 Q1	–	Sell	-60	Closed	–	–	9800
2020 Q4	$0	Buy	+60	New	+$107	﹤0.01%	8999

UBS Group's PTRAW Position: Q4 2021 in Review

UBS Group sold out of Proterra Inc. Warrant (PTRAW) in Q4 2021, closing a stake of 12,597 shares — an estimated $33K sold.

UBS Group first reported a position in PTRAW in Q4 2020 and held it in 2 quarters. The position peaked at $33K in Q3 2021. 0 funds tracked by Wall St. Rank hold PTRAW as of Q4 2021.

UBS Group reported no remaining Proterra Inc. Warrant position as of Q4 2021 after selling out during the quarter.
UBS Group sold 12,597 Proterra Inc. Warrant shares in Q4 2021, an estimated $33K.
UBS Group first reported a position in Proterra Inc. Warrant in Q4 2020 and held it in 2 quarters.
UBS Group's Proterra Inc. Warrant position peaked at $33K in Q3 2021.
0 funds tracked by Wall St. Rank held Proterra Inc. Warrant as of Q4 2021.

Based on UBS Group's 13F filing for Q4 2021, filed 14 Feb 2022.